DB-1310 is under clinical development by Duality Biologics (Shanghai) and curren...
Sirolimus is under clinical development by OrphAI Therapeutics and currently in ...
Sirolimus is under clinical development by OrphAI Therapeutics and currently in ...
DB-1310 is under clinical development by Duality Biologics (Shanghai) and curren...
DB-1310 is under clinical development by Duality Biologics (Shanghai) and curren...
BIO’s new CEO, John Crowley, is a longtime board member — and the inspiration fo...
CVS, the nation’s largest drugstore chain, will move away from the complex formu...
Eight months into his tenure, Johnson & Johnson’s R&D chief is putting a big emp...
Despite financial pressure to focus on adults, "we will go kids-first,” vows the...
Pfizer, Moderna, GSK, and Sanofi are all working on mRNA flu shots. But how well...
Anti-abortion laws intended to protect the unborn threaten lifesaving fetal surg...
President Biden’s new plan to curb drug shortages won't help with cancer drug sh...
The FDA will need dozens more reviewers if its so-called Operation Warp Speed fo...
In the wake of the Covid-19 pandemic, the FDA inspected far fewer domestic and f...
The Senate health care committee will soon consider a sweeping bill that, if pas...
The Supreme Court on Monday wrestled with a nationwide settlement with OxyContin...
